COMMENT

Covid-19 vaccine inequity: the debate over patent waivers intensifies

Covid-19 vaccines show efficacy in adolescents, paving path towards herd immunity

International pharmacovigilance for biotechs: forming a strategy

insight

A new era for Alzheimer’s drugs

Alzheimer’s disease treatment has gained ground after the US FDA approval of Biogen’s Aduhelm

insight

Europe reports the highest prevalence of chronic cough

comment

Could vaccine hesitancy impact hearing disorders?

Covid-19 vaccine inequity: the debate over patent waivers intensifies

Covid-19 vaccines show efficacy in adolescents, paving path towards herd immunity

International pharmacovigilance for biotechs: forming a strategy

02/23/2024 23:13:36
  • Home | Time for UK plasma to shine
  • In this issue
  • Contents
  • Datwyler
  • Labcorp
  • UPS Healthcare Company Insight
  • UPS Healthcare
  • Baxter
  • SHL Medical
  • Briefing
  • Industry news
  • The pharma industry briefing
  • Covid-19 executive briefing by GlobalData
  • Mimotopes Company Insight
  • Mimotopes
  • PerkinElmer
  • Comment
  • A new day for Alzheimer’s disease treatment
  • Covid-19 vaccine inequity: the debate over patent waivers intensifies
  • Covid-19 vaccines show efficacy in adolescents
  • International pharmacovigilance for biotechs: forming a strategy
  • Nipro
  • HOF Sonderanlagenbau
  • Myonex
  • In Depth
  • Malaria vaccines through the ages
  • Are competition authorities tightening the rules on pharma M&A?
  • The fishy business of shark squalene
  • Without a trace: can pharma reduce scarring?
  • Blood plasma production: OK for the UK?
  • When the drugs don’t work: can pharma keep up with mental health?
  • The Solubility Company - Company Insight
  • The Solubility company
  • Owen Mumford Company Insight
  • Owen Mumford
  • In Data
  • Deals analysis
  • The pharma industry key list
  • Global markets and indices
  • Macro-economic indicators
  • Macro-economic indicators (page 2)
  • Events
  • Next issue
06/18/2021 00:00:00